LAB WORK: Research associates Mitchell McAlister and Olivia Morin work in the lab at EpiVax in Providence. The biotechnology company recently began working on a coronavirus vaccine. / PBN PHOTO/MICHAEL SALERNO
Staying current on the frantic pace of the coronavirus outbreak means following reports by major news outlets for most people, but analysts at EpiVax Inc. are more interested in websites that share genetic sequences of the novel virus. Chinese health officials published the sequence in late January, and within a week, a team at Providence-based…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
